Austin, United States, Aug. 20, 2026 (GLOBE NEWSWIRE) -- The Bioprocess Analyzers Market was valued at USD 2.42 Billion in 2025 and is projected to reach USD 7.71 Billion by 2035, growing at a CAGR of 12.34% during 2026–2035, according to SNS Insider. Increasing production of biologicals, increasing application of real-time monitoring processes, and rising applications of PAT are some of the factors that are boosting the market.
The Bioprocess Analyzers Market is growing fast since there are increasing investments being made by pharmaceutical and biotech companies in sophisticated analytical instruments to measure, analyze, and control processes used in the manufacture of biopharmaceuticals. Bioprocess analyzers allow the measuring of key process parameters to improve the process uniformity, quality of products, efficiency, and compliance. The increasing production of monoclonal antibodies, vaccines, recombinant proteins, biosimilars, and cell and gene therapies drives up demand for analytical tools.
Download the Bioprocess Analyzers Market Sample Report: https://www.snsinsider.com/sample-request/10747
Key Takeaways:
- Leading Product: Instruments (~63.00% share)
- Leading Technology: In-Line Monitoring (~46.00% share)
- Leading Application: Recombinant Proteins (~39.00% share)
- Leading End User: Biopharmaceutical Companies (~51.00% share)
- Largest Regional Market: North America (~37% share)
- Fastest-Growing Regional Market: Asia Pacific
Biologics Manufacturing and Real-Time Monitoring Drive Bioprocess Analyzers Market Growth
Increased biologic, vaccine, monoclonal antibody, recombinant protein, biosimilar, and cell and gene therapy production has been driving the need for more advanced bioprocess monitoring tools. With the increasing use of Process Analytical Technology, automation, continuous bioprocessing, and real-time analysis, companies can now have an easier time improving product quality, ensuring process reproducibility, increasing efficiency, and maintaining compliance..
Bioprocess Analyzers Market Segmentation Analysis
By Product: Instruments Lead the Bioprocess Analyzers Market by Product
Instruments constitute the biggest segment of the total biopharmaceutical monitoring market and have a share of about 63.00% in 2025 due to their extensive use in measuring and controlling important variables during biopharmaceutical manufacturing processes. The most rapidly growing segment of the market is Consumables & Accessories, due to the repetitive nature of use of sensors, reagents, and samples, among others.
By Technology: In-Line Monitoring Dominates Bioprocess Analysis Technology
The In-Line Monitoring segment had the lead share of about 46.00% in 2025, which is the prominent technology segment for continuous monitoring of process parameters in real time. The In-Line Monitoring segment is also the rapidly growing technology segment at a CAGR of 13.06% during the forecast period 2026-2035, driven by the increasing use of advanced sensors, Process Analytical Technology (PAT), and control systems.
By Application: Recombinant Proteins Hold the Largest Application Share
The application segment of Recombinant Proteins held the largest market share of 39.00% in 2025 because of extensive usage and production of recombinant proteins in pharmaceutical and therapeutic applications. The Biosimilars application market is growing at the highest CAGR because of the growing demand for cost-effective biologicals and biosimilar production investment.
By End User: Biopharmaceutical Companies Lead End-User Demand
Biopharmaceutical Companies accounted for the highest market share of nearly 51.00% as they extensively used analytical systems in their research, development, and production process of biologics. The fastest-growing end-user segment was CROs & CMOs with a CAGR of 14.15% during 2026-2035, due to the rising trend of outsourcing activities such as research, development, testing, and manufacturing.
North America Leads the Bioprocess Analyzers Market While Asia Pacific Records the Fastest Growth
In 2025, North America will dominate 37% of the total market because of the presence of dominant players in the biopharmaceutical sector, robust biomanufacturing technology base, and adoption of real-time process monitoring technologies. Ecosystem reinforcement has been done with huge investment in biologics, cell & gene therapy, continuous bioprocessing, and advanced analytics due to positive regulatory environment and large-scale research and development spending.
The value of the U.S. Bioprocess Analyzers Market in 2025 was around USD 0.76 billion and projected to reach USD 2.30 billion by 2035, growing at a CAGR of 11.74% from 2026 to 2035. The United States currently holds the position of the largest market in North America due to the increase in the production of biopharmaceuticals, production of monoclonal antibodies and cell/gene therapies, and advancements in real-time process monitoring technology.
Europe Bioprocess Analyzers Market was worth USD 0.75 Billion in 2025 and expected to reach USD 2.33 Billion by 2035, registering a CAGR of 12.00% from 2026 to 2035. Growth factors for the Europe region include existence of well-developed pharmaceuticals and biotechnology industry, production of biologics, quality requirement and increasing use of continuous manufacturing processes and process optimization and automation.
The Asia Pacific region dominates in terms of market growth due to the fast-growing production of biopharmaceutical products, development of biotechnology facilities and adoption of process analytical technology in countries such as China, India, South Korea, and Singapore. The contribution of China to the regional revenue was around 38.9%, attributed to growth in production of biopharmaceutical products, vaccines, biosimilars and development of biotechnology facilities.
Explore the Complete Bioprocess Analyzers Market Report: https://www.snsinsider.com/reports/bioprocess-analyzers-market-10747
Leading Market Players Listed in this Report are:
- Agilent Technologies, Inc.
- Danaher Corporation
- Eppendorf AG
- F. Hoffmann-La Roche Ltd.
- Nova Biomedical
- Randox Laboratories Ltd.
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Mettler-Toledo International Inc.
- Waters Corporation
- Endress+Hauser Group
- Beckman Coulter Life Sciences
- Cytiva
- Hamilton Company
- Shimadzu Corporation
- HORIBA, Ltd.
- Merck KGaA
- 4BioCell GmbH & Co. KG
- SYSBIOTECH GmbH
- Kaiser Optical Systems, Inc.
Recent Developments
- 2025: Sartorius launched the Eveo Cell Therapy Platform, integrating automated production and quality control to improve process efficiency, scalability, and analytical capabilities for advanced cell therapy manufacturing.
- 2025: Hamilton announced GlucoSense, a reusable in-situ glucose sensor providing continuous real-time measurements inside mammalian cell-culture bioreactors, strengthening automated bioprocess monitoring and control.
Bioprocess Analyzers Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 2.42 Billion |
| Market Size by 2035 | USD 7.71 Billion |
| CAGR | CAGR of 12.34 % From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Product (Instruments, Consumables & Accessories) • By Technology (In-Line Monitoring, At-Line Monitoring, Off-Line Monitoring) • By Application (Antibiotics, Recombinant Proteins, Biosimilars, Other Applications) • By End User (Biopharmaceutical Companies, Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs), Research & Academic Institutes, Other End Users) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Buy the Bioprocess Analyzers Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/10747
USPs – Bioprocess Analyzers Market:
- Real-Time Process Monitoring: Increasing adoption of in-line and at-line monitoring technologies for continuous bioprocess analysis.
- Strong Biologics Demand: Rising production of monoclonal antibodies, vaccines, recombinant proteins, and cell & gene therapies.
- PAT & Automation Adoption: Growing implementation of Process Analytical Technology and automated analytical systems.
- High-Growth Asia Pacific: Asia Pacific is projected to be the fastest-growing regional market, supported by expanding biopharmaceutical manufacturing.
- Strong U.S. Market: The U.S. market is projected to grow from USD 0.76 Billion in 2025 to USD 2.30 Billion by 2035.
- Fastest-Growing Segments: Consumables & Accessories, In-Line Monitoring, Biosimilars, and CROs & CMOs offer strong growth opportunities.
- Advanced Analytical Technologies: Integration of spectroscopy, chromatography, sensors, AI, and data analytics is improving process optimization.
- Broad Biopharma Applications: Bioprocess analyzers support research, development, and commercial manufacturing across multiple biologics applications.
Related Market Reports
Process Analytical Technology Market Size 2026
Process Analyzer Market Growth 2026
Upstream Bioprocessing Market Trends 2026
Large And Small Scale Bioprocessing Market Outlook 2026
Bioprocess Validation Market Analysis 2026
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
